Effect of TEAS on pain and survival after liver surgery
Efficacy of Transcutaneous Electrical Acupoint Stimulation on Chronic Pain and Survival in Patients Undergoing Hepatectomy: a Prospective, Randomized Controlled Trial
NA · West China Hospital · NCT06406244
This study tests if a special electrical treatment can help reduce pain and improve survival for people having liver surgery for cancer.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 524 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | West China Hospital (other) |
| Locations | 1 site (Chengdu) |
| Trial ID | NCT06406244 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of transcutaneous electrical acupoint stimulation (TEAS) in reducing postoperative chronic pain and improving survival rates in patients undergoing hepatectomy for liver cancer. Participants will be randomly assigned to receive either TEAS or a sham treatment, with TEAS applied before and after surgery at specific acupoints. The study will follow patients to assess chronic pain, quality of life, and survival outcomes at 3 and 6 months post-surgery.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-80 scheduled for elective hepatectomy with ASA physical status class I-III.
Not a fit: Patients with a history of epilepsy, chronic opioid use, or other specified exclusions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce chronic pain and improve survival rates for patients undergoing liver surgery.
How similar studies have performed: Previous studies have shown promising results with TEAS in managing pain, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Age 18-80 years old; ASA physical status classⅠ-Ⅲ; Patients scheduled for elective hepatectomy. Exclusion Criteria: Have a history of epilepsy; Rash or local infection over the acupoint stimulation skin area; Pregnancy or breastfeeding; Mental retardation, psychiatric, or neurological disease; Inability to comprehend the numeric rating scale (NRS); Implantation of a cardiac pacemaker, cardioverter, or defibrillator; Chronic opioid use; Metastases in other organs.
Where this trial is running
Chengdu
- West China Hospital — Chengdu, China (RECRUITING)
Study contacts
- Study coordinator: Chunling Jiang, PhD
- Email: jiang_chunling@yahoo.com
- Phone: 18980601096
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Liver Cancer